Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Fungus – except allergen – or component thereof or substance...
Patent
1981-07-23
1984-04-10
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Fungus, except allergen, or component thereof or substance...
A61K 3140
Patent
active
044421184
ABSTRACT:
Disclosed are new methods of using 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid, or a therapeutically acceptable salt thereof with an organic or inorganic base for the treatment of complications associated with diabetes mellitus. The compound inhibits lens aldose reductase in a diabetic mammal.
REFERENCES:
Chemical Abstracts 91: 49605u (1979).
Chaudbury et al., J. Diab. Ass. India, 16/2, pp. 59-64 (1976).
Schlumpf, Schiveiz Med. Wochenscher 108/1, pp. 28-34 (1978).
Widstron, Horm, Metab. Res. 9/3, pp. 172-175 (1977).
Dvornik Dushan M.
Simard-Duquesne Nicole
Ayerst McKenna & Harrison, Inc.
Goldberg Jerome D.
Mandel Adley F.
LandOfFree
Aldose reductase inhibition by 1-(4-chlorobenzoyl)-5-methoxy-2-m does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aldose reductase inhibition by 1-(4-chlorobenzoyl)-5-methoxy-2-m, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aldose reductase inhibition by 1-(4-chlorobenzoyl)-5-methoxy-2-m will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-892621